Embracing Technologies & Enhancing Outcomes
October 22, 2018
Examining the hottest trends and techniques in drug development.
1 min read
Welcome to the October issue. Upfront investigates next-generation pain medications developed with computer simulations, antibiotics derived from bear saliva, and the costs of falsified medicine. Daniel Maier argues that the development of an industrial process should begin when the product is still at the preclinical stage in “In My View”, while our cover feature examines the urgent need for pharma to generate data on safety for pregnant and lactating women and their fetuses and babies. In Best Practice, Mike Merges and Mike Sadick from Catalent discuss how to get analytical bioassay cell banks up and running, and in Business, we explore a proactive approach to discovering and investing in future leaders. We also Sit Down With…Kal Patel, MD, Senior Vice President of Digital Health for Flex.
October 22, 2018
Examining the hottest trends and techniques in drug development.
1 min read
October 22, 2018
Experts prepare to gather in Ireland to discuss Industry 4.0 – and whether it has a place in the biopharma industry
1 min read
October 17, 2018
Sitting Down With…Kal Patel, MD, Senior Vice President of Digital Health for Flex.
1 min read
October 17, 2018
Are people born to lead or can they be cultivated? Here, I share how we take a proactive approach to discovering and investing in future leaders.
1 min read
October 17, 2018
Analytical bioassay cell banks certainly have benefits. But with little guidance on how to get them up and running, it can be difficult to know what best practices to follow.
1 min read
October 17, 2018
Frank Fischer and Sven Poetzsch have a shared goal at Merck: to understand how medicines interact with human biology. In this pursuit, cutting-edge omics research is key.
1 min read
October 17, 2018
1 min read
October 17, 2018
For the vast majority of pharmaceutical products, data on safety for pregnant and lactating women and their fetuses and babies is not available. But going without essential medication is not the right solution – failing to treat health conditions could lead to equal or increased risk for mother and child. Here, we seek the path to a more enlightened approach.
1 min read
October 17, 2018
How well do you really know your process? Modeling and simulation can reveal new information that can help you better prepare both your process and facility for the future.
1 min read
October 17, 2018
Digital technology is all around us, but pharma isn’t quite getting it right… yet.
1 min read
October 17, 2018
The development of an industrial process should begin right at the start – when the product is still at the preclinical stage.
1 min read
October 17, 2018
Working with a CDMO is more than just gaining an extra pair of hands – a good CDMO is a true partner with advice on getting the most from your molecule.
1 min read
October 17, 2018
A company looks to give the humble injection an inventive makeover with a new competition
1 min read
October 17, 2018
A recent review and meta-analysis highlights the huge impact of fake and substandard drugs on health, trust in healthcare, and the economy
1 min read
October 17, 2018
A new method for discovering antibiotics makes use of an unusual source of complex microbial communities
1 min read
October 17, 2018
Nominations for The Medicine Maker’s annual Innovation Awards will close on Tuesday November 6, 2018
1 min read
October 17, 2018
Next-generation pain medications developed with computer simulations could improve on current opioid offerings
1 min read
October 17, 2018
A new center for electron bio-imaging was officially opened by one of the three Nobel Prize winners behind the cutting-edge technology at its heart
1 min read
October 17, 2018
It’s time for maternal health to escape from the dark ages, and pharma has a duty to help.
1 min read
False
False